RPRoopa Kalsank Pai

Roopa Kalsank Pai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Roopa Kalsank Pai has a total of 53 co-authors. Here are the top co-authors by number of shared publications:

  • Agnes Flöel

    Department of Neurology, University Medicine Greifswald, Greifswald, Germany

    1 shared publication
  • Alex Upton

    CSCS Swiss National Supercomputing Centre, Lugano, Switzerland

    1 shared publication
  • Alexander Peyser

    SimLab Neuroscience, Jülich Supercomputing Centre (JSC), Institute for Advanced Simulation, JARA, Forschungszentrum Jülich GmbH, Jülich, Germany

    1 shared publication
  • Ana Solodkin

    1 shared publication
  • André Blickensdörfer

    Berlin Institute of Health at Charité, Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Department of Neurology with Experimental Neurology, Charitéplatz 1, 10117 Berlin, Germany

    1 shared publication
  • Anne Nahm

    Jülich Supercomputer Centre, Forschungszentrum Jülich, Jülich, Germany

    1 shared publication

Latest Publications

  • Top Cited Papers
    Open Access

    Brain simulation as a cloud service: The Virtual Brain on EBRAINS

    by Michael Schirner, Lia Domide, Dionysios Perdikis, Paul Triebkorn, Leon Stefanovski, Roopa Pai, Paula Prodan, Bogdan Valean, Jessica Palmer, Chloê Langford, et al.


  • Open Access

    From genes to network models of Alzheimer's disease: Biological framework for multi-scale brain simulation with The Virtual Brain

    by Leon Stefanovski, Jil Mona Meier, Roopa Kalsank Pai, Paul Triebkorn, Tristram Lett, Leon Martin, Konstantin Bülau, Martin Hofmann-Apitius, Ana Solodkin, Anthony Randal McIntosh, et al.

    While the knowledge in neuroscience and the possibilities in clinical neurology have improved for many years, neurogenerative diseases and associated dementia remain a growing problem. Alzheimer’s Disease (AD) is the most common cause of dementia and also represents the most prevalent type of neurodegenerative diseases. For AD, disease-modifying treatments are presently lacking and the understanding of disease mechanisms remain incomplete. In the present review, we consider candidate contributing factors leading to AD and we evaluate novel computational brain simulation methods to further disentangle their potential roles. We first discuss existing computational models of AD that aim to provide a mechanistic understanding of the disease. Next, we outline the potential to link molecular aspects of neurodegeneration in AD with large-scale brain network modeling using The Virtual Brain (TVB, www.thevirtualbrain.org), an open-source, multi- scale, whole-brain simulation neuroinformatics platform. Finally, we discuss how this methodological approach may contribute to the understanding, improved diagnostics and treatment of AD.